named programs · 1 · from sources
What they call their work
Academy for Health & Lifespan Research
Global network of elite scientists and clinicians focused on geroscience research, collaboration, and policy advocacy to treat aging as a medical condition.
activities · 5 groups
What they do
-
Scientific Conference & Symposium Management 2 activities
- Convenes and unites global geroscience expertsActs as a catalyst and convening body by uniting world-renowned researchers, scientists, and clinicians in the field of geroscience to empower collaboration, accelerate drug development targeting aging, and support high-impact events that advance the field.
- Hosts annual conferences convening global leaders in geroscienceOrganizes and hosts annual international conferences that bring together leading scientists, clinicians, and researchers in the field of aging and longevity, including gatherings in Paris, West Palm Beach, and Rancho Palos Verdes, to establish collective strategies, reflect on mission, and plan future initiatives in aging research.
-
-
Research and Scholarly Fellowship Support 1 activity
- Builds capacity in geroscience through training and fellowshipsOffers immersive educational programs including a summer course on the biology of aging and the Viviana Goren Khazzam Communications Fellowship, which provides $5,000 stipends, mentorship, and fully funded access to Academy events to support science communication in geroscience.
-
-
Advancing Geroscience Research and Translation 1 activity
- Conducts and funds geroscience research to modify aging biologyAdvances basic and translational research in geroscience to target aging as a root cause of age-related diseases, with goals to extend healthspan, reduce chronic illness burden, and develop interventions such as those based on time-restricted eating and chromatin stability mechanisms like "chromostasis." Includes conducting original research, publishing findings from clinical trials, and coining new scientific concepts such as cytoplasmic chromatin fragments (CCF) and DNA methylation clocks in mice.
-
-
Medical Research Funding 1 activity
- Funds scientific conferences and workshops in aging researchAwards grants to support scientific meetings, conferences, and workshops aligned with its mission to accelerate longevity science, including through quarterly grant review cycles. These funded events serve as platforms for strategic planning and integration of gerotherapeutics into clinical practice.
-
-
Uncategorized 1 activity
- Leads scientific journal editorial efforts in aging researchSupports scholarly communication in geroscience through leadership roles in academic publishing, including serving as co-Editor-in-Chief of Aging Cell (2012–2022) and founding Editor of Aging Biology.
-
financials · form 990 · fy2024
revenue
Total revenue$934K
Contributions & grants$924K99%
Program service revenue$00%
Investment income$10K1%
Other revenue$0
expenses
Total expenses$720K
Program expenses67%
Admin / overhead33%
Fundraising0%
Salaries & benefits$235K
Grants paid out$88K
Largest expense lineCompensation
balance sheet
Total assets$616K
Cash$616K
Investments$0
Liabilities$17K
Net assets$600K
Liquid reserves10.3 mo
3 years on record · 2022–2024 · YoY revenue +105.6%
leadership · form 990 part vii · fy2024
Who runs it
paid leadership · 2
| Name | Title | Hours/wk | Compensation |
|---|---|---|---|
| Courtney Hudson-Paz | Executive Dir. | 40 | $120K |
| Risa Starr | Executive Dir. | 40 | $60K |
relationships · 47
Who they work with
- Alex Zhavoronkov Partner — Guest speaker at the 5th AHLR Annual Conference, sharing insights on AI's role in developing gerotherapeutics.
- Ana Maria Cuervo Partner — Expert host at the 4th AHLR Annual Conference, discussing advances in understanding aging hallmarks.
- Andrea Maier Partner — Panelist at the 4th AHLR Annual Conference, envisioning the future of longevity medicine in clinical settings.
- Andrea Maier Partner — Scientific advisor or collaborator promoting the integration of aging biology into clinical medicine.
- Anne Newman, PhD Partner — Contributing author to the publication "The Epidemiology of Aging" under the Academy's library.
- Brian Kennedy Partner — Expert host at the 4th AHLR Annual Conference, highlighting promising molecules for human longevity.
- Calico Life Sciences Partner — Hosts member Cynthia Kenyon, PhD
- David Glass Partner — Guest speaker at the 5th AHLR Annual Conference, presenting on pharmaceutical strategies in geroscience.
- David Le Couteur, PhD Partner — Co-author of the publication "Calorie Restriction, Aging and Longevity" featured in the Academy's library.
- David Sinclair Partner — Session leader at the 3rd AHLR Annual Conference, contributing to discussions on geroscience transformation and emerging research.
- David Sinclair, PhD Partner — Author of the publication "Lifespan: Why We Age―and Why We Don't Have To" featured in the Academy's library.
- EPFL Partner — Hosts member Johan Auwerx, MD, PhD
- Felipe Sierra Partner — Session leader at the 3rd AHLR Annual Conference, involved in defining member expectations and strategic goals.
- George Kuchel Partner — Expert host at the 4th AHLR Annual Conference, leading discussions on immunity and aging.
- Guido Kroener Partner — Scientific advisor or collaborator supporting the organization's mission in aging research.
- ICSA Partner — Co-organized the 10th Annual ICSA Conference with the Academy for Health & Lifespan Research Inc in 2025.
- Jamie Justice Partner — Panelist at the 4th AHLR Annual Conference, discussing the X-Prize Healthspan initiative.
- Jamie Metzl Partner — Panelist at the 4th AHLR Annual Conference, reshaping understanding of lifespan in the age of technology.
- Jan Vijg, PhD Partner — Author of multiple publications including "Aging of the Genome," "The American Technological Challenge," and "Faith and Fortune in the Creation of Our Modern World" featured in the Academy's library.
- Jim Kirkland Partner — Expert host at the 4th AHLR Annual Conference, providing updates on human clinical trials in aging research.
- Juan Carlos Izpisua Belmonte Partner — Expert host at the 4th AHLR Annual Conference, presenting on reversing cellular aging.
- Lee Hood Partner — Guest speaker at the 5th AHLR Annual Conference, discussing personalized medicine in aging research.
- MIT Partner — Hosts member Leonard Guarente, Ph.D
- Nature Partner — Founders have been featured in Nature.
- Nir Barzalai Partner — Scientific advisor or collaborator advancing research on healthspan and longevity therapeutics.
- Nir Barzilai Partner — Session leader at the 3rd AHLR Annual Conference, covering the Academy’s founding, strategic goals, and research areas.
- Paris Descartes Partner — Hosts member Guido Kroemer, MD, PhD
- Phaedon Institute Partner — Co-hosted the 2nd Phaedon Institute SenoTherapeutics Summit alongside the Academy for Health & Lifespan Research Inc in 2025.
- Rafael de Cabo Partner — Expert host at the 4th AHLR Annual Conference, exploring encouraging lifestyle interventions for longevity.
- Rafael de Cabo, PhD Partner — Co-author of the publication "Calorie Restriction, Aging and Longevity" featured in the Academy's library.
+ 17 more
strategies · 3
How they approach the work
Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.
- Accelerate Translation of Longevity Research Through Collaborationmethodology: collaborative_translationBy convening scientists, clinicians, and technologists through networks and conferences, the organization fosters collaborative innovation that bridges basic research and clinical application, accelerating the development of therapies that target aging.
- Advance Geroscience to Extend Healthspanmethodology: geroscienceBy focusing research and investment on geroscience—the study of aging as a biological driver of disease—the organization seeks to prevent multiple age-related conditions simultaneously, extending the human healthspan through interventions that modify underlying aging processes.
- Reframe Aging as a Treatable Conditionmethodology: aging_as_a_treatable_conditionBy advocating for the classification of aging as a treatable medical condition, the organization aims to shift research, clinical, and policy priorities toward targeting the biological processes of aging itself, thereby enabling preventative approaches to age-related diseases and unlocking new pathways for drug development and reimbursement.